" then what changed their minds and on what points of consideration should be the questions" -
I have asked this of you before- it is a fact that something has changed otherwise the submission would not be proceeding. The only public acknowledgment has been an acceptance of improvement in the potency assay.
I think you cop the heat for arguing that what caused the second BLA, is still the status quo.
The company thinks otherwise,
the TYPE A thrashes things out- the TYPE C was for feedback on data , no more meetings
- resubmit
not long to wait now
Reg
" then what changed their minds and on what points of...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.030(2.67%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $2.828M | 2.568M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 38498 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 119650 | 12 |
View Market Depth
| Last trade - 12.59pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |